.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
UBS
Argus Health
Johnson and Johnson
Cipla
Citi
Moodys
Deloitte
Fuji

Generated: June 24, 2017

DrugPatentWatch Database Preview

Naratriptan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naratriptan hydrochloride and what is the scope of naratriptan hydrochloride freedom to operate?

Naratriptan hydrochloride
is the generic ingredient in two branded drugs marketed by Heritage Pharms Inc, Paddock Llc, Mylan Pharms Inc, Orchid Hlthcare, Teva Pharms, Sun Pharm Inds Ltd, Glaxosmithkline Llc, Apotex Corp, West-ward Pharms Int, and Sandoz, and is included in ten NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naratriptan hydrochloride. Eight suppliers are listed for this compound.

Summary for Generic Name: naratriptan hydrochloride

Tradenames:2
Patents:1
Applicants:10
NDAs:10
Drug Master File Entries: see list6
Suppliers / Packagers: see list8
Bulk Api Vendors: see list48
Clinical Trials: see list2,250
Patent Applications: see list539
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naratriptan hydrochloride at DailyMed

Pharmacology for Ingredient: naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091441-001Apr 30, 2012ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091552-001Feb 14, 2011ABRXNoNo► Subscribe► Subscribe
Sandoz
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL090288-002Jul 7, 2010ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL090381-001Jul 7, 2010ABRXNoNo► Subscribe► Subscribe
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 1998ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-002Feb 10, 19984,997,841► Subscribe
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 19984,997,841► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Cerilliant
Mallinckrodt
Chubb
Deloitte
Argus Health
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot